Skip to main content
SpringerLink
Log in

HCV genotype sequencing before treatment worth extra cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Polilli E, et al. Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district. ClinicoEconomics and Outcomes Research : 14 Sep 2016. Available from: URL: https://dx.doi.org/10.2147/CEOR.S106238

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HCV genotype sequencing before treatment worth extra cost. PharmacoEcon Outcomes News 762, 20 (2016). https://doi.org/10.1007/s40274-016-3396-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3396-3

Search

Navigation